An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Westchester Medical Center, Valhalla

Hospital Reina Sofia, Córdoba

Allegheny General Hospital, Pittsburgh

Hopital Saint Jacques, Besançon

Hospital Occe de Octubre, Madrid

Carolinas Medical Center, Charlotte

Emory University Hospital, Atlanta

Medical College of Georgia, Augusta

Florida Hospital Medical Center and Translife, Orlando

University of Alabama, Birmingham

Centre Hospitalier Universitaire, Grenoble

University of Kentucky Medical Center, Lexington

University of Michigan Hospital, Ann Arbor

Medical College of Wisconsin, Milwaukee

Hopital de Bradois, Cedex

Hopital Edouard Herriot, Lyon

Rush University Transplant Program, Chicago

University of Texas Medical Branch, Galveston

UCLA School of Medicine, Los Angeles

Hopital Foch, Suresnes

California Pacific Medical Center, San Francisco

Yale University School of Medicine, New Haven

St. Barnabas Medical Center, Livingston

Unicersitat Erlangen-Numberg, Erlangen

University Hospital Eppendorf, Hamburg

Hospital de Cruces, Barakaldo

Freeman Hospital, Newcastle upon Tyne

Hospital Clinico Universitario, Barcelona